PHIO FY 2025 Earnings — Phio Pharmaceuticals Corp. Revenue & Financial Results | Market Cap Arena

PHIOPhio Pharmaceuticals Corp.

$13M

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$3,000

Operating Income

-$9M

Net Income

-$9M

EPS (Diluted)

$-1.45

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$9M

Stock-Based Comp.

$481,000

Balance Sheet

Total Assets

$21M

Total Liabilities

$1M

Stockholders' Equity

$20M

Cash & Equivalents

$21M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$3,000	-$4M	+99.9%
Operating Income	-$9M	-$7M	-24.8%
Net Income	-$9M	-$7M	-21.7%